Nurix Therapeutics (NRIX) Net Income Growth (3y) (2022 - 2026)
Nurix Therapeutics (NRIX) Net Income Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | 9.16% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn | 79.26% |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn | 47.10% |
| 10 | Nurix Therapeutics | 2.60 Bn | 2.16 Bn | - | -54.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -54.50% |
| Feb 28, 2026 | -29.25% |
| Nov 30, 2025 | -18.75% |
| Aug 31, 2025 | -23.65% |
| May 31, 2025 | 1.44% |
| Feb 28, 2025 | -9.83% |
| Nov 30, 2024 | -15.82% |
| Aug 31, 2024 | -19.27% |
| May 31, 2024 | -19.14% |
| Feb 29, 2024 | -19.59% |
| Nov 30, 2023 | -28.15% |
| Aug 31, 2023 | -25.93% |
| May 31, 2023 | -73.28% |
| Feb 28, 2023 | -48.69% |
| Nov 30, 2022 | -51.33% |
| Aug 31, 2022 | -166.06% |